{{Rsnum
|rsid=570613
|Gene=GATA3
|Chromosome=10
|position=8106502
|Orientation=minus
|GMAF=0.3627
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 40.7 | 44.2 | 15.0
| HCB | 47.4 | 46.7 | 5.8
| JPT | 38.9 | 48.7 | 12.4
| YRI | 28.6 | 51.7 | 19.7
| ASW | 29.8 | 57.9 | 12.3
| CHB | 47.4 | 46.7 | 5.8
| CHD | 50.5 | 41.3 | 8.3
| GIH | 49.5 | 38.6 | 11.9
| LWK | 40.0 | 42.7 | 17.3
| MEX | 25.9 | 62.1 | 12.1
| MKK | 18.6 | 51.3 | 30.1
| TSI | 35.3 | 55.9 | 8.8
| HapMapRevision=28
}}A study of 6,388 cases and 4,995 controls from the Breast Cancer Association Consortium (BCAC) and 5,617 BRCA1 and BRCA2 carriers from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) concluded that there is no evidence that [[rs570613]] is associated with breast cancer risk in women.{{PMID|19082709|OA=1
}}

{{PMID Auto
|PMID=18006915
|Title=Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status.
}}

{{PMID Auto
|PMID=18410415
|Title=Polymorphisms in the interleukin 13 and GATA binding protein 3 genes and the development of eczema during childhood.
|OA=1
}}

{{PMID Auto
|PMID=18505952
|Title=Genetic susceptibility to cancer: the role of polymorphisms in candidate genes.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}